Cellivery 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iCP-NI / Cellivery
NCT05740280: iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Suspended
1
64
US
iCP-NI, Placebo
Cellivery Therapeutics, Inc., Labcorp Corporation of America Holdings, Inc
Healthy Volunteers
08/23
08/23
CV-06 / Cellivery, Ildong
No trials found
CV-14 / Takeda
No trials found

Download Options